Dizhe medicine: juxtaposed with the largest shareholder, directors and executives to extend the share lock-in period
Cailian news agency, Jan. 18 (by wire) according to the announcement of Dizhe medicine, the company's pre IPO share lock held by the first largest shareholder advanced manufacturing industry investment fund (hereinafter referred to as "advanced manufacturing") and Astra Zeneca AB (hereinafter referred to as "azab") was extended for 6 months to June 9, 2025. The company's directors The lock of shares held by senior managers before the initial public offering of the company shall be extended for 6 months to January 15, 2024.
This text is a result of machine translation.
Briefing Updated 8 hours ago
· Financials
The US dollar fell more than 1% against the Japanese yen USD / JPY and is now at 128.06.
Briefing Updated 6 hours ago
· Financials
Reduce down payment subsidies and adjust real estate policies more
In-depth
Financials, Healthcare
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Briefing Updated 5 hours ago
· Technology
The Swiss federal government issued a decree to strengthen natural gas reserves
May 02, 2022 07:50 PM
Apr 26, 2022 12:26 PM
Apr 21, 2022 07:07 PM
Apr 18, 2022 09:14 PM
Briefing Updated 5 hours ago
· Financials
23 Hang Seng technology QDII platforms with eye-catching performance, good economy and "overweight" long-term configuration value
Briefing Updated 5 hours ago
· Healthcare
Mozambique has reported polio cases for the first time in 30 years
Briefing Updated 4 hours ago
· Healthcare
The Spanish Ministry of health has confirmed that 7 suspected cases of monkeypox have tested positive
Healthcare
Nucleic Acid Drug CDMO Olipharma Raises Tens of Mns of CNY in Pre-Series A Round
As a new way to treat diseases, gene therapy has higher R&D investment and risk than biochemical drugs. Both pharmaceutical giants and start-ups tend to collaborate with outsourcing service providers, which brings business opportunities to cell and gene therapy contract development and manufacturing organizations (CDMOs).
Yesterday 09:59 PM
Briefing Updated 2 hours ago
· Financials
Financial associated press commentary: the decline in the P / E ratio of new shares is the role of the market mechanism
Briefing Updated 2 hours ago
· Technology
Revision of the basic law of nuclear fusion breaking through the limit of fuel density
Briefing Updated 11 mins ago
· Technology
US Treasury Secretary: the US government's seizure of frozen assets of the Russian central bank is "illegal"
Technology
China Satellite Navigation and Location Services Industry Reached CNY 469 Billion
According to the GNSS and LBS Association of China's White Paper on the Development of China's Satellite Navigation and Location Services Industry (2022), China's Satellite Navigation and Location Services Industry grew by 16.29 % year over year, reaching CNY 469 billion.
Yesterday 06:56 PM
Briefing Updated 1 hour ago
· Financials
The main capital continued to flow into 57 shares for more than 5 consecutive days
Briefing Updated 1 hour ago
· Technology
Russia may cut off gas supplies to Finland this week
See more
Read next
In-depth
In-depth
In-depth
Financials, Healthcare
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
May 12, 2022 05:41 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.